TriSalus Life Sciences (TLSI) EBIT (2021 - 2026)
TriSalus Life Sciences (TLSI) reported EBIT of -$8.4 million for Q1 2026, down 14.76% on a YoY basis from -$9.9 million in Q1 2025, and down 157.14% quarter-over-quarter from -$3.3 million in Q4 2025.
TriSalus Life Sciences (TLSI) EBIT (2021 - 2026) Analysis & Trends
TriSalus Life Sciences has reported EBIT for 6 years, with the latest figure at -$8.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 14.76% year-over-year to -$8.4 million; the trailing twelve-month figure through Mar 2026 stood at -$28.0 million (up 11.92% YoY), and the FY2025 full-year result was -$26.9 million, up 25.49% from the prior year.
- EBIT for Q1 2026 stood at -$8.4 million, down from -$3.3 million in the prior quarter.
- The five-year high for EBIT was -$288273.0 in Q2 2022, with the low at -$18.6 million in Q3 2023.
- Historically, EBIT has averaged -$8.6 million across 5 years, with a median of -$8.4 million in 2026.
- Annual changes were most pronounced in 2022 — EBIT jumped 63.23% — and 2023, when it slumped 3866.38%.
- TriSalus Life Sciences' EBIT stood at -$11.8 million in 2022, then declined by 21.03% to -$14.2 million in 2023, then jumped by 46.8% to -$7.6 million in 2024, then soared by 56.85% to -$3.3 million in 2025, then plunged by 157.14% to -$8.4 million in 2026.
- The last three EBIT figures came in at -$8.4 million (Q1 2026), -$3.3 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | TriSalus Life Sciences | 209.25 Mn | 152.70 Mn | 7.67 Mn | -8.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.41 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Sep 30, 2025 | -9.01 Mn |
| Jun 30, 2025 | -7.33 Mn |
| Mar 31, 2025 | -7.33 Mn |
| Dec 31, 2024 | -7.58 Mn |
| Sep 30, 2024 | -8.74 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Mar 31, 2024 | -11.67 Mn |
| Dec 31, 2023 | -14.25 Mn |
| Sep 30, 2023 | -18.62 Mn |
| Jun 30, 2023 | -11.43 Mn |
| Mar 31, 2023 | -10.12 Mn |
| Dec 31, 2022 | -11.77 Mn |
| Sep 30, 2022 | -8.11 Mn |
| Jun 30, 2022 | -288,273.00 |
| Mar 31, 2022 | -669,807.00 |
| Dec 31, 2021 | -1.14 Mn |
| Sep 30, 2021 | -807,259.00 |
| Jun 30, 2021 | -783,925.00 |